28th Jul 2008 16:00
Tepnel Life Sciences plc ('Tepnel' or 'the Company')
Tepnel to announce interim results for 2008
Manchester, UK - 28th July 2008 Tepnel Life Sciences PLC (AIM: TED), the UK-based international Molecular Diagnostics and Research Products & Services group, will release its interim results for the 6 months ended 30 June 2008 on Thursday, July 31, 2008 at approximately 7:00am UK time.
-End-
For Further Information:
Tepnel Life Sciences plc
Ben Matzilevich, CEO; Mick Slater, Group Finance Director; Carol Smith, Group Marketing Communications Manager
0161 946 2200
Capital MS&L
Mary Clark or Joey Whineray
Tel: +44 20 7307 5330
Seymour Pierce Limited
Mark Percy
Tel: +44 20 7107 8000
Notes to Editors
About Tepnel Life Sciences plc
Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences products and services group with two main divisions, Molecular Diagnostics and Research Products & Services. The Company has laboratories, manufacturing and operations in the USA, UK and France with 215 employees. TLS provides test kits, reagents and services to two highly synergistic markets, these being Molecular Diagnostics and Biomedical Research. The company's strategy has been to identify high growth niche opportunities within these multi-billion pound markets. TLS focuses on these niche opportunities with internally developed products, patents, expertise and know-how as well as strategic acquisitions, to develop a leadership position within these defined market segments.
Related Shares:
TED.L